We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNHC
1876
DELISTED
FedNat Holding Company Common Stock
FNHC
| $366K | ﹤0.01% |
22,100
+10,500
| +91% | +$156K |
|
|
TAX
1877
DELISTED
Liberty Tax, Inc. Class A
TAX
| $366K | ﹤0.01% |
33,300
+6,100
| +22% | +$76.4K |
|
1878
Franklin Covey
FC
$233M
| $365K | ﹤0.01% |
17,600
-2,100
| -11% | -$41.2K |
|
1879
ORIX
IX
$44B
| $365K | ﹤0.01% |
21,500
+1,000
| +5% | +$16.9K |
|
|
SAND
1880
DELISTED
Sandstorm Gold
SAND
| $365K | ﹤0.01% |
+73,131
| New | +$332K |
|
1881
Protagonist Therapeutics
PTGX
$8.75B
| $362K | ﹤0.01% |
+17,400
| New | +$309K |
|
|
BREW
1882
DELISTED
Craft Brew Alliance, Inc.
BREW
| $361K | ﹤0.01% |
18,800
+5,800
| +45% | +$109K |
|
|
SONC
1883
DELISTED
Sonic Corp
SONC
| $361K | ﹤0.01% |
13,152
-155,000
| -92% | -$4M |
|
1884
Seres Therapeutics
MCRB
$48M
| $360K | ﹤0.01% |
1,775
+1,075
| +154% | +$221K |
|
1885
Park Aerospace
PKE
$745M
| $359K | ﹤0.01% |
18,281
-16,400
| -47% | -$313K |
|
|
SVM
1886
Silvercorp Metals
SVM
$2.13B
| $359K | ﹤0.01% |
137,300
+5,500
| +4% | +$14K |
|
|
OXFD
1887
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $359K | ﹤0.01% |
25,700
-12,200
| -32% | -$179K |
|
|
PSDO
1888
DELISTED
Presidio, Inc. Common Stock
PSDO
| $356K | ﹤0.01% |
+18,574
| New | +$292K |
|
|
HIVE
1889
DELISTED
Aerohive Networks
HIVE
| $356K | ﹤0.01% |
+61,000
| New | +$294K |
|
1890
Red Robin
RRGB
$134M
| $355K | ﹤0.01% |
6,300
-7,735
| -55% | -$445K |
|
|
FONR
1891
DELISTED
Fonar
FONR
| $353K | ﹤0.01% |
14,500
-5,600
| -28% | -$155K |
|
1892
NextEra Energy
NEE
$187B
| $353K | ﹤0.01% |
9,052
-468,000
| -98% | -$18.1M |
|
|
FOGO
1893
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $351K | ﹤0.01% |
30,300
+1,500
| +5% | +$17.3K |
|
1894
Core Molding Technologies
CMT
$210M
| $349K | ﹤0.01% |
16,100
-4,000
| -20% | -$88.2K |
|
|
FARM
1895
DELISTED
Farmer Brothers
FARM
| $347K | ﹤0.01% |
10,800
+1,600
| +17% | +$52.8K |
|
1896
NBT Bancorp
NBTB
$2.72B
| $346K | ﹤0.01% |
9,392
-6,078
| -39% | -$229K |
|
1897
Clearfield
CLFD
$421M
| $345K | ﹤0.01% |
28,200
-200
| -0.7% | -$2.69K |
|
1898
Banco Bradesco
BBD
$38.1B
| $343K | ﹤0.01% |
58,832
-48,479
| -45% | -$290K |
|
|
RVNC
1899
DELISTED
Revance Therapeutics, Inc.
RVNC
| $343K | ﹤0.01% |
+9,600
| New | +$276K |
|
|
ARAV
1900
DELISTED
Aravive, Inc. Common Stock
ARAV
| $343K | ﹤0.01% |
25,950
+10,117
| +64% | +$130K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.